Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
On a field-in-field breast tangent plan do you have a minimum MU you accept for a subfield?
Answer from: Radiation Oncologist at Community Practice
I usually avoid sub field with MU, less than 4-5 as adds little to plan quality and increases treatment time.
Sign in or Register to read more
15098
Related Questions
What is the appropriate approach to manage a patient with triple-negative, locally advanced breast cancer (LN+) who progresses on neoadjuvant chemo-immunotherapy (KEYNOTE-522 regimen)?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
Would you recommend PMRT for multifocal IDC with extensive LVI and 1 SLN with ITCs?
Does your dosimetrist use skin flash for VMAT whole breast or RNI plans?
Would you forgo lumpectomy cavity boost for grade 1 papillary carcinoma with associated grade 1 DCIS that has been resected with good margins?
How would you approach an isolated supraclavicular nodal recurrence involving the skin in a patient who has received standard chest wall and nodal radiation therapy?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?